Pietro Invernizzi Selected Research

Arylalkylamine N-Acetyltransferase

1/2019	Pinealectomy or light exposure exacerbates biliary damage and liver fibrosis in cholestatic rats through decreased melatonin synthesis.
10/2017	Prolonged darkness reduces liver fibrosis in a mouse model of primary sclerosing cholangitis by miR-200b down-regulation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Pietro Invernizzi Research Topics

Disease

87	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 01/2022 - 07/2003
30	Fibrosis (Cirrhosis) 01/2022 - 06/2005
26	Neoplasms (Cancer) 09/2022 - 08/2004
24	Liver Diseases (Liver Disease) 11/2020 - 10/2007
21	Sclerosing Cholangitis 01/2022 - 06/2008
20	Cholangiocarcinoma 09/2022 - 10/2007
19	Autoimmune Diseases (Autoimmune Disease) 08/2017 - 07/2003
17	Liver Cirrhosis (Hepatic Cirrhosis) 01/2022 - 10/2003
14	Cholestasis 01/2021 - 10/2003
12	Autoimmune Hepatitis 01/2022 - 06/2008
12	Inflammation (Inflammations) 01/2020 - 03/2010
10	COVID-19 01/2022 - 09/2020
9	Disease Progression 01/2022 - 08/2009
8	Infections 05/2022 - 04/2005
6	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2022 - 03/2012
5	Hepatocellular Carcinoma (Hepatoma) 09/2022 - 11/2010
5	Hyperplasia 01/2020 - 10/2017
4	Cholangitis 03/2013 - 05/2010
3	Liver Neoplasms (Liver Cancer) 09/2022 - 01/2017
3	Pruritus (Itching) 01/2021 - 06/2008
3	Liver Failure 12/2020 - 12/2011
2	Insulin Resistance 05/2022 - 12/2019
2	Gastrinoma 03/2022 - 09/2021
2	Zollinger-Ellison Syndrome (Syndrome, Zollinger-Ellison) 03/2022 - 09/2021
2	End Stage Liver Disease 01/2022 - 08/2009
2	Genetic Predisposition to Disease (Genetic Predisposition) 10/2020 - 07/2013
2	Iron Overload 01/2020 - 01/2019
2	Fatty Liver 01/2020 - 04/2011
2	Necrosis 05/2015 - 05/2010
2	Turner Syndrome (Turner's Syndrome) 12/2012 - 07/2005

Drug/Important Bio-Agent (IBA)

24	AutoantibodiesIBA 01/2021 - 08/2005
19	AntibodiesIBA 09/2020 - 11/2004
16	Ursodeoxycholic Acid (Urso)FDA LinkGeneric 04/2021 - 11/2010
11	Biomarkers (Surrogate Marker)IBA 01/2022 - 05/2006
11	AntigensIBA 09/2020 - 08/2004
11	Proteins (Proteins, Gene)FDA Link 11/2019 - 11/2004
9	Alkaline PhosphataseIBA 12/2021 - 04/2011
8	EnzymesIBA 09/2020 - 11/2004
6	Bile Acids and Salts (Bile Acids)IBA 01/2022 - 04/2011
6	BilirubinIBA 12/2021 - 12/2014
6	Pharmaceutical PreparationsIBA 04/2021 - 02/2018
6	AutoantigensIBA 11/2019 - 03/2010
6	Immunoglobulin M (IgM)IBA 01/2018 - 04/2005
5	obeticholic acidIBA 04/2021 - 08/2016
5	CytokinesIBA 08/2015 - 06/2005
4	Pyruvate Dehydrogenase Complex (Dehydrogenase Complex, Pyruvate)IBA 01/2022 - 03/2009
4	Secretin FDA Link 09/2021 - 06/2014
4	SteroidsIBA 09/2020 - 05/2012
4	Histamine (Histamine Dihydrochloride)FDA Link 12/2019 - 10/2016
4	MicroRNAs (MicroRNA)IBA 12/2016 - 03/2012
4	XenobioticsIBA 12/2012 - 11/2003
3	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 03/2022 - 01/2020
3	GastrinsIBA 03/2022 - 01/2020
3	AcidsIBA 03/2022 - 11/2010
3	Adrenal Cortex Hormones (Corticosteroids)IBA 09/2021 - 12/2020
3	Immunoglobulin G (IgG)IBA 12/2020 - 12/2010
3	Serotonin (5 Hydroxytryptamine)IBA 01/2020 - 11/2008
3	MorpholinosIBA 12/2019 - 01/2017
3	MelatoninIBA 01/2019 - 10/2011
3	IronIBA 01/2019 - 10/2012
3	ATP-Binding Cassette Sub-Family B Member 4IBA 01/2019 - 11/2010
3	Hormones (Hormone)IBA 01/2019 - 06/2005
3	CD40 Ligand (CD40L)IBA 01/2018 - 06/2005
3	Therapeutic UsesIBA 10/2017 - 02/2005
3	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2017 - 02/2016
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2014 - 09/2009
2	6-propylchromone-2-carboxylic acid (PCCA)IBA 09/2022 - 01/2021
2	Somatostatin Receptors (Somatostatin Receptor)IBA 03/2022 - 09/2021
2	Nucleic AcidsIBA 01/2022 - 01/2019
2	Dexamethasone (Maxidex)FDA LinkGeneric 01/2022 - 01/2019
2	AvidinIBA 01/2022 - 01/2019
2	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 01/2021 - 12/2016
2	Fibric Acids (Fibrates)IBA 01/2021 - 11/2020
2	Transaminases (Aminotransferases)IBA 12/2020 - 12/2016
2	Serum AlbuminIBA 11/2020 - 01/2018
2	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 11/2020 - 01/2019
2	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 09/2020 - 06/2008
2	Monoamine Oxidase (MAO)IBA 01/2020 - 11/2008
2	Tryptophan HydroxylaseIBA 01/2020 - 11/2008
2	Antinuclear AntibodiesIBA 07/2019 - 08/2005
2	Phosphotransferases (Kinase)IBA 01/2019 - 05/2017
2	Interleukin-13IBA 01/2019 - 01/2017
2	Arylalkylamine N-AcetyltransferaseIBA 01/2019 - 10/2017
2	NF-kappa B (NF-kB)IBA 01/2019 - 01/2016
2	secretin receptorIBA 01/2019 - 01/2016
2	Fibronectins (Fibronectin)IBA 01/2017 - 10/2016
2	Immunoglobulins (Immunoglobulin)IBA 12/2016 - 05/2010
2	Biological ProductsIBA 01/2015 - 08/2013
2	Interleukin-12 (IL 12)IBA 04/2014 - 03/2012
2	Immunologic Factors (Immunomodulators)IBA 11/2013 - 06/2009
2	Calcitriol Receptors (Calcitriol Receptor)IBA 11/2013 - 06/2009
2	Nuclear Antigens (Extractable Nuclear Antigens)IBA 02/2012 - 12/2010

Therapy/Procedure

31	Therapeutics 09/2021 - 11/2010
14	Liver Transplantation 01/2022 - 06/2008
5	Precision Medicine 01/2020 - 08/2016
4	Drug Therapy (Chemotherapy) 01/2020 - 11/2008
3	Transplantation 05/2022 - 02/2018
3	Aftercare (After-Treatment) 01/2020 - 05/2011
2	Artificial Respiration (Mechanical Ventilation) 01/2022 - 01/2021
2	Ligation 01/2019 - 06/2014